127 related articles for article (PubMed ID: 8981054)
21. Central mu opioid receptor-mediated changes in renal function in conscious rats.
Kapusta DR; Obih JC; Dibona GF
J Pharmacol Exp Ther; 1993 Apr; 265(1):134-43. PubMed ID: 8097241
[TBL] [Abstract][Full Text] [Related]
22. Electrophysiological studies on the spinal effects of dermorphin, an endogenous mu-opioid agonist.
Sullivan AF; Dickenson AH
Brain Res; 1988 Sep; 461(1):182-5. PubMed ID: 2906269
[TBL] [Abstract][Full Text] [Related]
23. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
24. Modulation of breathing by mu1 and mu2 opioid receptor stimulation in neonatal and adult rats.
Colman AS; Miller JH
Respir Physiol; 2001 Sep; 127(2-3):157-72. PubMed ID: 11504587
[TBL] [Abstract][Full Text] [Related]
25. The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse.
Tseng LF
Jpn J Pharmacol; 2002 Jul; 89(3):216-20. PubMed ID: 12184724
[TBL] [Abstract][Full Text] [Related]
26. The synthesis and opioid receptor binding affinities of analogues of dermorphin and its N-terminal tetrapeptide fragment with dibasic acids in position 2.
Misicka A; Lipkowski AW; Slaninova J; Davis P; Yamamura HI; Porreca F; Hruby VJ
Life Sci; 1995; 57(18):1633-40. PubMed ID: 7475903
[TBL] [Abstract][Full Text] [Related]
27. Preparation and binding properties of radioiodinated analogues of dermorphin and deltorphin with high specificity for the mu- and delta-opioid receptors.
Gaudriault G; Zsürger N; Vincent JP
J Neurochem; 1997 Feb; 68(2):813-9. PubMed ID: 9003073
[TBL] [Abstract][Full Text] [Related]
28. Different effects of peptidase inhibitors on dermorphin- and on [D-Arg2]dermorphin-induced antinociceptive activity.
Sakurada S; Watanabe H; Sakurada T; Kisara K; Sasaki Y; Suzuki K
Eur J Pharmacol; 1992 Jan; 211(1):75-80. PubMed ID: 1352249
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6.
Biondi L; Giannini E; Filira F; Gobbo M; Marastoni M; Negri L; Scolaro B; Tomatisc R; Rocchi R
J Pept Sci; 2003 Oct; 9(10):638-48. PubMed ID: 14620129
[TBL] [Abstract][Full Text] [Related]
30. Cross-tolerance between the different mu-opioid receptor agonists endomorphin-1, endomorphin-2 and morphine at the spinal level in the rat.
Labuz D; Przewlocki R; Przewlocka B
Neurosci Lett; 2002 Dec; 334(2):127-30. PubMed ID: 12435488
[TBL] [Abstract][Full Text] [Related]
31. Respiratory mu-opioid and benzodiazepine interactions in the unrestrained rat.
Paakkari P; Paakkari I; Landes P; Sirén AL; Feuerstein G
Neuropharmacology; 1993 Apr; 32(4):323-9. PubMed ID: 8098861
[TBL] [Abstract][Full Text] [Related]
32. [Dermorphins--a natural opioids with unique primary structure that determines their biological specificity].
Usenko AB; Emel'ianova TG; Miasoedov NF
Izv Akad Nauk Ser Biol; 2002; (2):192-204. PubMed ID: 11963546
[TBL] [Abstract][Full Text] [Related]
33. Renal mu opioid receptor mechanisms in regulation of renal function in rats.
Kapusta DR; Jones SY; DiBona GF
J Pharmacol Exp Ther; 1991 Jul; 258(1):111-7. PubMed ID: 1677034
[TBL] [Abstract][Full Text] [Related]
34. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo opioid activity of [DPro(6)]dermorphin, a new dermorphin analogue.
Broccardo M; Usenko AB; Uranova MG; Guzevatykh LS; Kamensky AA; Andreeva LA; Alfeeva LY; Myasoedov NF; Giannini E; Improta G; Emel'yanova TG
Peptides; 2003 Mar; 24(3):419-28. PubMed ID: 12732340
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the antinociceptive effects of new [D-Arg2]-dermorphin tetrapeptide analogs and morphine in mice.
Chaki K; Sakurada S; Sakurada T; Sato T; Kawamura S; Kisara K; Watanabe H; Suzuki K
Pharmacol Biochem Behav; 1988 Oct; 31(2):439-44. PubMed ID: 2907624
[TBL] [Abstract][Full Text] [Related]
37. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids.
Yaksh TL; Malmberg AB; Ro S; Schiller P; Goodman M
J Pharmacol Exp Ther; 1995 Oct; 275(1):63-72. PubMed ID: 7562596
[TBL] [Abstract][Full Text] [Related]
39. Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion.
degli Uberti EC; Trasforini G; Salvadori S; Margutti A; Tomatis R; Rotola C; Bianconi M; Pansini R
Neuroendocrinology; 1983 Oct; 37(4):280-3. PubMed ID: 6633818
[TBL] [Abstract][Full Text] [Related]
40. Dimeric dermorphin peptides: central administration suppresses gastric acid secretion through interaction with mu-type opioid receptor.
Guglietta A; Irons BJ; Lazarus LH; de Castiglione R; Melchiorri P
Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):663-70. PubMed ID: 2560103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
